BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• 

  BioMidwest

  Baxter International, Inc.'s Deal With Merrimack Pharmaceuticals Inc. All Upside: Analyst

  September 26, 2014

   · 

  1 min read
• 

  Biotech Bay

  Gilead Sciences, Inc.'s Harvoni Will Fast Track: Analyst

  September 26, 2014

   · 

  1 min read
• 

  Deals

  Bay Area Biosimilar Firm Coherus Biosciences Eyes $86.25 Million IPO

  September 26, 2014

   · 

  2 min read
• 

  Ebola - It’s Far, Far Worse Than You Thought

  September 26, 2014

   · 

  1 min read
• 

  Biotech Bay

  The Pharma Trend That Should Scare The Crap Out Of Medical Device Sales Reps

  September 26, 2014

   · 

  1 min read
• FDA

  Alimera Sciences, pSivida Corp Eye Implant Finally Wins FDA Approval

  September 26, 2014

   · 

  10 min read
• FDA Says Novartis AG, Roche’s Asthma Drug Xolair Raises Risk Of Heart, Brain Problems

  September 26, 2014

   · 

  1 min read
• Policy

  Bristol-Myers Squibb Company’s Immunotherapy Drug Opdivo Gets Six Month FDA Review For Melanoma

  September 26, 2014

   · 

  8 min read
• Business

  Exelixis, Inc. Taps Deborah Burke As New CFO

  September 26, 2014

   · 

  1 min read
• Biotech Beach

  REVA Medical Inc. Secures $25 Million

  September 26, 2014

   · 

  22 min read